December 16, 2020
MSD K.K., the Japan arm of US Merck, has started a voluntary recall for its broad-spectrum antibiotic Zerbaxa (ceftolozane + tazobactam) and suspended its shipments after some lots of the product failed in sterility testing. The company decided to recall...read more